Virtus Fund Advisers’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,908
Closed -$23.9K 139
2024
Q3
$23.9K Sell
1,908
-1,192
-38% -$13K 0.1% 103
2024
Q2
$26.4K Hold
3,100
0.1% 98
2024
Q1
$32.6K Hold
3,100
0.12% 85
2023
Q4
$32.2K Buy
+3,100
New +$24.7K 0.2% 76

Other funds holding ZYME

Virtus Fund Advisers's ZYME Position: Q4 2024 in Review

Virtus Fund Advisers sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 1,908 shares — an estimated $23.9K sold.

Virtus Fund Advisers first reported a position in ZYME in Q4 2023 and held it in 4 quarters. The position peaked at $32.6K in Q1 2024. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Virtus Fund Advisers reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,908 Zymeworks shares in Q4 2024, an estimated $23.9K.
  • Virtus Fund Advisers first reported a position in Zymeworks in Q4 2023 and held it in 4 quarters.
  • Virtus Fund Advisers's Zymeworks position peaked at $32.6K in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.